Security
AMST · Amesite Inc.
AMSTNASDAQCommon stockCurrentCIK 1807166Updated Sep 27, 2026
Name history
Amesite Operating Co · through Sep 22, 2020
AMST price & chart
Loading TradingView…
NASDAQ:AMST on TradingView ↗About the company
Amesite is a technology company focused on building and commercializing AI-powered solutions for the healthcare sector, with particular emphasis on the post-acute care market. In fiscal 2025, we completed our pivot from an education-centric model to one firmly anchored in the demands and opportunities of healthcare—a shift driven by the scale, complexity, and attractive growth potential of this sector.
In the news
Recent filings
10-K filing
Shareholder Director Nominations · Other Events
Items 5.08, 8.01
Regulation FD Disclosure
Items 7.01, 9.01
S-8 filing
Entry into a Material Definitive Agreement
Items 1.01, 9.01
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 3,029,637Source | 3,097,099Source | 3,314,177Source | 6,349,752Source |
| Property, Plant and Equipment, NetUSD | 19,619Source | 39,436Source | 64,784Source | 88,966Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,298,809Source | 2,333,418Source | 2,071,016Source | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 14,726Source | 6,341Source | 30,060Source | — |
| Assets, CurrentUSD | 2,412,984Source | 2,433,859Source | 2,604,565Source | 5,482,340Source |
| Prepaid Expense and Other Assets, CurrentUSD | 99,449Source | 94,100Source | 403,489Source | 106,679Source |
| LIABILITIES AND EQUITY | ||||
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | — | — | 0Source |
| Common Stock, Value, IssuedUSD | 655Source | 458Source | 255Source | 255Source |
| Additional Paid in CapitalUSD | 47,199,489Source | 44,188,632Source | 40,348,958Source | 39,514,489Source |
| Retained Earnings (Accumulated Deficit)USD | -44,546,425Source | -41,450,587Source | -37,833,501Source | -33,430,319Source |
| Stockholders' Equity Attributable to ParentUSD | 2,653,719Source | 2,738,503Source | 2,515,712Source | 6,084,425Source |
| Liabilities and EquityUSD | 3,029,637Source | 3,097,099Source | 3,314,177Source | 6,349,752Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 375,918Source | 358,596Source | 798,465Source | 265,327Source |
| Accounts Payable, CurrentUSD | 50,493Source | 25,413Source | 48,907Source | 70,070Source |
| Additional Financial Items | ||||
| Deferred Revenue, CurrentUSD | — | — | — | 53,958Source |
cash flow · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | — | 433,803Source | 533,667Source | 682,483Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 268,127Source | 226,053Source | 834,469Source | 179,534Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 25,662Source | -23,719Source | 15,060Source | 455Source |
| Increase (Decrease) in Accounts PayableUSD | 25,080Source | -23,494Source | -21,163Source | -52,212Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -2,146,717Source | -2,455,248Source | -2,813,779Source | -3,249,176Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -230,819Source | -378,300Source | -375,866Source | -396,033Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 5,721Source | — | 1,166Source | 27,124Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 2,342,927Source | 3,095,950Source | — | 1,850,503Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | -1,794,706Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,398,809Source | 2,433,418Source | 2,071,016Source | 5,360,661Source |
| Additional Financial Items | ||||
| AmortizationUSD | — | 408,455Source | — | — |
| Share-based Payment Arrangement, ExpenseUSD | — | 27,750Source | 900,000Source | — |
| Capitalized Computer Software, AmortizationUSD | 251,868Source | — | 508,318Source | — |
| DepreciationUSD | 25,538Source | 25,348Source | 25,349Source | 25,348Source |
| General and Administrative ExpenseUSD | 2,510,264Source | 2,477,888Source | 2,908,289Source | 2,492,777Source |
| Investment Income, InterestUSD | 47,268Source | 77,396Source | 176,469Source | — |
| Net Income (Loss) Attributable to ParentUSD | -3,095,838Source | -3,617,086Source | -4,403,182Source | -4,153,303Source |
| Nonoperating Income (Expense)USD | 47,268Source | -13,473Source | 176,469Source | — |
| Operating ExpensesUSD | 3,507,883Source | 3,714,072Source | 4,746,532Source | 5,069,517Source |
| Other Depreciation and AmortizationUSD | — | 55,503Source | — | — |
| Proceeds from Issuance of Common StockUSD | 2,342,927Source | 3,095,950Source | — | 1,850,503Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 364,777Source | — | — | — |
| Share-based Payment Arrangement, Expensed and Capitalized, AmountUSD | — | — | — | 179,534Source |
| Stock or Unit Option Plan ExpenseUSD | — | 20,303Source | 18,137Source | — |
income statement · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total RevenueUSD | 364,777Source | 110,459Source | 166,881Source | 845,009Source |
| Operating Income (Loss)USD | -3,143,106Source | -3,603,613Source | -4,579,651Source | -4,224,508Source |
| Net Income (Loss) Attributable to ParentUSD | -3,095,838Source | -3,617,086Source | -4,403,182Source | -4,153,303Source |
| Earnings Per Share, BasicUSD per share | -0.63Source | -1.03Source | -1.73Source | -1.68Source |
| Earnings Per Share, DilutedUSD per share | -0.63Source | -1.03Source | -1.73Source | -1.68Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 4,937,520Source | 3,525,672Source | 2,542,440Source | 2,469,890Source |
| Additional Financial Items | ||||
| Capitalized Computer Software, AmortizationUSD | 251,868Source | — | 508,318Source | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | 277,406Source | — | — | — |
| General and Administrative ExpenseUSD | 2,510,264Source | 2,477,888Source | 2,908,289Source | 2,492,777Source |
| Investment Income, InterestUSD | 47,268Source | 77,396Source | 176,469Source | — |
| Marketing and Advertising ExpenseUSD | 142,700Source | 174,227Source | — | — |
| Nonoperating Income (Expense)USD | 47,268Source | -13,473Source | 176,469Source | — |
| Operating ExpensesUSD | 3,507,883Source | 3,714,072Source | 4,746,532Source | 5,069,517Source |
| Research and Development ExpenseUSD | 613,578Source | 691,154Source | — | 1,523,547Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 364,777Source | — | — | — |
| Selling and Marketing ExpenseUSD | 384,041Source | 545,030Source | 763,915Source | 1,053,193Source |
| Share-based Payment Arrangement, Expensed and Capitalized, AmountUSD | — | — | — | 179,534Source |
Offerings
Registration 333-295814
Registration 333-295187
Filing attachments
ea030534601ex99-1.htm · 8-K · 2026-09-11
EX-99.1 2 ea030534601ex99-1.htm PRESENTATION MATERIALS - SEPTEMBER 2026 Exhibit 99.1 NASDAQ: AMST Shareholder Update Q2 2027 September 9, 2026 © 2026 Amesite Inc. All Rights Reserved. 1 This presentation may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. For such forward-looking statements, we claim the protection of the safe harbor for forward-looking statements contai…
Read attachment ↗ea029141601ex99-1.htm · 8-K · 2026-05-19
EX-99.1 2 ea029141601ex99-1.htm PRESS RELEASE DATED MAY 18, 2026 Exhibit 99.1 Amesite’s NurseMagic™ Wins 2,700-Census Home Care Enterprise Customer Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute Care DETROIT, May 18, 2026 (GLOBE NEWSWIRE) - Amesite Inc. (Nasdaq: AMST), developer of the AI-native NurseMagic™ documentation platform and EMR for non-acute care, today announced it has secured a new enterprise custome…
Read attachment ↗ea028797001ex4-1.htm · 8-K · 2026-04-28
EX-4.1 2 ea028797001ex4-1.htm FORM OF PRE-FUNDED WARRANT Exhibit 4.1 PRE-FUNDED COMMON STOCK PURCHASE WARRANT AMESITE INC. Warrant Shares: _______ Issue Date:______, 2026 Initial Exercise Date: _______, 2026 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter se…
Read attachment ↗ea028797001ex4-2.htm · 8-K · 2026-04-28
EX-4.2 3 ea028797001ex4-2.htm FORM OF SERIES A-1 WARRANT Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES A…
Read attachment ↗ea028797001ex4-3.htm · 8-K · 2026-04-28
EX-4.3 4 ea028797001ex4-3.htm FORM OF SERIES A-2 WARRANT Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES A…
Read attachment ↗ea028797001ex4-4.htm · 8-K · 2026-04-28
EX-4.4 5 ea028797001ex4-4.htm FORM OF PLACEMENT AGENT WARRANT Exhibit 4.4 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURIT…
Read attachment ↗